logo

For the Inventor, By the Inventor

Turku, Finland

Heikki Irjala

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: Faron Pharmaceuticals Oy. Active years: 2008-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Heikki Irjala. Retrieved from https://idiyas.com/inventor/heikki-irjala

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2

% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:

goldMedal2 out of 16 
 
Faron Pharmaceuticals Oy
 patents

Years Active: 2008-2011

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents
1. 7910097 - Common lymphatic endothelial and vascular endothelial receptor-1 (CLEVER-1) and uses thereof (2011-03-22),
2. 7354577 - Common lymphatic endothelial and vascular endothelial receptor-1 (CLEVER-1) and uses thereof (2008-04-08),

Title: The Innovative Mind of Heikki Irjala

Introduction: Heikki Irjala is a pioneering inventor hailing from Turku, Finland, known for his groundbreaking contributions to various technological fields.

Latest Patents: Heikki Irjala holds several patents in the areas of renewable energy, sustainable transportation, and advanced materials, showcasing his commitment to creating a more sustainable future.

Career Highlights: With a career spanning over two decades, Heikki Irjala has worked with leading research institutions and companies to develop cutting-edge technologies that have revolutionized industries worldwide.

Collaborations: Throughout his career, Heikki Irjala has collaborated with top engineers, scientists, and innovators, fostering a culture of creativity and excellence in all his projects.

Conclusion: Heikki Irjala's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…